Cytarabine
- Product NDC
- 67457-452
- 11-digit product format
- 674570452
- Labeler code
- 67457
- Product ID
- 67457-452_b2177d45-d94b-4ab5-8387-fc4702c1447a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cytarabine
- Dosage form
- INJECTION
- Route
- INTRATHECAL; INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Mylan Institutional LLC
- Application
- ANDA201784
- Marketing category
- ANDA
- Marketing start
- 2012-01-31
- Marketing end
- 2022-12-31
- Substance
- CYTARABINE
- Active strength
- 2 g/20mL
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67457-452-20 | 67457045220 | 1 VIAL in 1 CARTON (67457-452-20) > 20 mL in 1 VIAL | 1 vial | 2012-01-31 | 0000-00-00 | No | No | Current |